BridgeBio Pharma, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of BBIO for the last quarter is 1.75 M USD, and it's 57.35% lower compared to the previous quarter. The net income of Q4 23 is -168.15 M USD.